Frazier Kenneth C insider trades
Frazier Kenneth C has filed 11 Form 4s with the SEC that we hold, for Merck & Co., Inc. (MRK) (Executive Chair, Director), Eikon Therapeutics, Inc. (EIKN) (Director) and XOM (Director). Across all of them we count 1 purchase worth $2.0M and 19 sales worth $271.5M reported on Form 4. In the last 12 months: 1 purchase ($2.0M) and 0 sales ($0). The largest single trade was a sale of 634,266 shares of Merck & Co., Inc. worth $52.1M, dated 2021-11-09. The first filing on our record is dated 2021-11-10 and the latest 2026-03-04.
Merck & Co., Inc. (MRK)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-11-09 | S, sale reported on Form 4 | 634,266 | $52.1M | 2021-11-10 |
| 2021-11-09 | S, sale reported on Form 4 | 29,615 | $2.5M | 2021-11-10 |
| 2022-10-28 | S, sale reported on Form 4 | 178,363 | $18.0M | 2022-11-01 |
| 2022-10-28 | S, sale reported on Form 4 | 313,232 | $31.4M | 2022-11-01 |
| 2022-10-28 | S, sale reported on Form 4 | 75,489 | $7.5M | 2022-11-01 |
| 2022-10-31 | S, sale reported on Form 4 | 229,302 | $23.2M | 2022-11-01 |
| 2022-10-31 | S, sale reported on Form 4 | 70,698 | $7.1M | 2022-11-01 |
| 2022-11-01 | S, sale reported on Form 4 | 202,319 | $20.2M | 2022-11-03 |
| 2022-11-01 | S, sale reported on Form 4 | 700 | $70.7K | 2022-11-03 |
| 2022-11-01 | S, sale reported on Form 4 | 96,981 | $9.7M | 2022-11-03 |
| 2022-11-02 | S, sale reported on Form 4 | 205,661 | $20.5M | 2022-11-03 |
| 2022-11-02 | S, sale reported on Form 4 | 94,339 | $9.5M | 2022-11-03 |
| 2022-11-03 | S, sale reported on Form 4 | 20,383 | $2.0M | 2022-11-07 |
| 2022-11-03 | S, sale reported on Form 4 | 214,617 | $21.2M | 2022-11-07 |
| 2022-11-04 | S, sale reported on Form 4 | 34,810 | $3.4M | 2022-11-07 |
| 2022-11-04 | S, sale reported on Form 4 | 200,190 | $19.7M | 2022-11-07 |
| 2022-11-07 | S, sale reported on Form 4 | 24,914 | $2.5M | 2022-11-08 |
| 2022-11-07 | S, sale reported on Form 4 | 84,721 | $8.5M | 2022-11-08 |
| 2022-11-07 | S, sale reported on Form 4 | 126,134 | $12.5M | 2022-11-08 |
Eikon Therapeutics, Inc. (EIKN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-04 | P, purchase reported on Form 4 | 111,111 | $2.0M | 2026-02-06 |
XOM (XOM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1181175) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms